Q/C Technologies (QCLS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Mar, 2026Executive summary
The annual meeting will be held virtually on November 25, 2024, with voting available online, by phone, or by mail.
Stockholders will vote on the election of seven directors, an amendment to the equity incentive plan, auditor ratification, and potential adjournment.
The Board recommends voting in favor of all proposals.
Voting matters and shareholder proposals
Proposals include electing seven directors, amending the 2021 Equity Incentive Plan to add 2,259,060 shares, ratifying Stephano Slack LLC as auditor, and authorizing adjournment if needed.
The Board unanimously recommends voting “FOR” all proposals.
Abstentions count as votes against all but the director election, where they have no effect.
No dissenters’ or appraisal rights are available for these matters.
Board of directors and corporate governance
Seven nominees, all current directors, are up for election for one-year terms.
The Board consists of a majority of independent directors as defined by Nasdaq rules.
Committees include Audit, Compensation, Nominating and Corporate Governance, and Risk and Disclosure.
The company has implemented governance reforms, including annual reviews of its Code of Business Ethics and a Whistleblower Policy.
Board diversity matrix shows all directors are male and white, with no formal diversity policy.
Latest events from Q/C Technologies
- Registering 6.5M shares for resale, with major dilution and capital needs amid business diversification.QCLS
Registration Filing6 Mar 2026 - Net loss increased to $27.2 million in 2024, with urgent need for new funding to sustain operations.QCLS
Q4 20246 Mar 2026 - Shareholders will vote on key proposals to enable major financings and expand authorized shares.QCLS
Proxy Filing6 Mar 2026 - Net loss narrowed, but going concern and Nasdaq compliance risks persist amid ongoing clinical development.QCLS
Q2 20256 Mar 2026 - Net loss reached $24M YTD; cash and securities at $10.6M; liquidity sufficient for 12 months.QCLS
Q3 20246 Mar 2026 - Transitioned to laser-based computing for blockchain, raising $9.4M and narrowing net loss.QCLS
Q3 20256 Mar 2026 - Net loss widened to $21.3M as new financings and warrant amendments strengthened liquidity.QCLS
Q2 20246 Mar 2026 - Shareholders will vote on director elections, capital structure changes, and key governance proposals.QCLS
Proxy Filing6 Mar 2026 - Shareholders to vote on major share issuances, incentive plan expansion, and a reverse stock split.QCLS
Proxy Filing6 Mar 2026